The Prescription Drugs (Pharmacies) market in Eastern Europe has been experiencing significant growth in recent years. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors have all contributed to this development. Customer preferences in Eastern Europe have shifted towards increased healthcare awareness and a growing demand for prescription drugs. As the population becomes more educated about health and wellness, there is a greater emphasis on preventative care and the use of prescription drugs to manage chronic conditions. This has led to an increased demand for pharmacies and prescription drugs in the region. Trends in the market indicate that there is a growing number of pharmacies in Eastern Europe to meet the rising demand. This increase in supply has been driven by both local and international pharmaceutical companies expanding their presence in the region. Additionally, there has been a rise in online pharmacies, providing customers with convenient access to prescription drugs. This trend is expected to continue as more consumers embrace digital solutions for their healthcare needs. Local special circumstances in Eastern Europe have also contributed to the development of the Prescription Drugs (Pharmacies) market. One key factor is the aging population in the region. As the population ages, there is a higher prevalence of chronic diseases, which require ongoing medication. This has led to an increased demand for prescription drugs and subsequently, the growth of pharmacies. Furthermore, Eastern Europe has witnessed a shift towards a more market-oriented healthcare system. This has resulted in increased competition among pharmacies, as well as the introduction of cost containment measures. Pharmacies are now required to compete on price, quality, and convenience, which has led to improvements in service and accessibility for customers. Underlying macroeconomic factors have also played a role in the development of the Prescription Drugs (Pharmacies) market in Eastern Europe. Economic growth in the region has resulted in increased disposable income, allowing individuals to afford prescription drugs. Additionally, government initiatives aimed at improving healthcare access and affordability have further fueled the growth of pharmacies. In conclusion, the Prescription Drugs (Pharmacies) market in Eastern Europe is experiencing significant growth due to changing customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors. As the region continues to prioritize healthcare and accessibility to prescription drugs, the market is expected to continue its upward trajectory.
Data coverage:
The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.Modeling approach:
Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.Additional notes:
The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
